Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer's disease: A genetic and proteomic multi-cohort study.

by Cynthia Picard, Alexandre Poirier, Stéphanie Bélanger, Anne Labonté, Daniel Auld, Judes Poirier, PREVENT-AD Research Group
Published 2019-01-01

No apparent effect of naproxen on CSF markers of innate immune activation

by Pierre‐François Meyer, Anne Labonté, Pedro Rosa‐Neto, Judes Poirier, John C. S. Breitner, the PREVENT‐AD Research Group
Published 2019-06-01

Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer’s disease

by Alexa Pichet Binette, Guillaume Theaud, François Rheault, Maggie Roy, D Louis Collins, Johannes Levin, Hiroshi Mori, Jae Hong Lee, Martin Rhys Farlow, Peter Schofield, Jasmeer P Chhatwal, Colin L Masters, Tammie Benzinger, John Morris, Randall Bateman, John CS Breitner, Judes Poirier, Julie Gonneaud, Maxime Descoteaux, Sylvia Villeneuve, DIAN Study Group, PREVENT-AD Research Group
Published 2021-05-01

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease

by Julie Gonneaud, Alex T. Baria, Alexa Pichet Binette, Brian A. Gordon, Jasmeer P. Chhatwal, Carlos Cruchaga, Mathias Jucker, Johannes Levin, Stephen Salloway, Martin Farlow, Serge Gauthier, Tammie L. S. Benzinger, John C. Morris, Randall J. Bateman, John C. S. Breitner, Judes Poirier, Etienne Vachon-Presseau, Sylvia Villeneuve, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Dominantly Inherited Alzheimer Network (DIAN) Study Group, Pre-symptomatic Evaluation of Experimental or Novel Treatments for Alzheimer’s Disease (PREVENT-AD) Research Group
Published 2021-09-01